Full-Time

Director of Metabolic and Inflammatory Diseases

Confirmed live in the last 24 hours

Flagship Pioneering

Flagship Pioneering

201-500 employees

Biotechnology firm creating health and sustainability solutions

Biotechnology
Healthcare

Senior

Cambridge, MA, USA

Category
Public Health
Biology Lab & Research
Biology & Biotech
Requirements
  • PhD or MS in metabolic, biochemistry, immunology or related field
  • Minimum 8+ years of experience in industry, leading and representing the metabolic disease function on project teams
  • A proven track record of displaying excellent interpersonal and communication skills both written and oral and ability to communicate complex information succinctly.
  • Extensive industry experience in the discovery and development of large molecule/biologics therapeutics in the context of metabolic disorders
  • Project leadership experience, preferably in context of biologics and/or the development of therapeutics that leverage ML/AI
  • Experience managing PhD and non-PhD scientists
  • Expertise in the biology of GPCRs, preferably in the context of biologics but relevant experience in development of small molecule therapeutics targeting GPCRs is sufficient
Responsibilities
  • Lead and build Metabolic and inflammatory focused research group at Metaphore Biotechnologies, setting the strategy and vision for the function in the context of the platform
  • Support the advancement of therapeutic candidates from discovery to late preclinical development
  • Play active role in shaping the metabolic/obesity and inflammatory disease portfolio at Metaphore, understanding platform capabilities and clinical unmet need to identify and pursue the development of novel therapeutics
  • Project leadership of development programs, cross-functionally leading team of computational scientists, protein engineers and translational scientists to effectively and efficiently develop therapeutics candidates
  • Set and manage budget for the group, including managing in-house and external resources to achieve program specific goals in timely and budget conscious manner
  • Build and lead a team of scientists, supporting their scientific and personal development

Flagship Pioneering fosters a culture of groundbreaking advancements in biotechnology, emphasizing an ecosystem approach that synergizes human health and sustainability. Their business model not only focuses on creating transformative products but also incubates leading companies like Moderna and Indigo Agriculture, positioning them at the forefront of scientific innovation and industry leadership. This approach offers employees a unique opportunity to be part of a pioneering team that drives real-world impacts across multiple sectors.

Company Stage

N/A

Total Funding

$10.2B

Headquarters

Cambridge, Massachusetts

Founded

2000

Simplify Jobs

Simplify's Take

What believers are saying

  • Flagship's recent $3.6 billion raise will support the creation of 25 new breakthrough companies, offering substantial growth opportunities.
  • The firm's track record of founding over 100 biotechnology companies, including industry leaders like Moderna, highlights its potential for high-impact innovation.
  • Key leadership appointments and promotions, such as Lovisa Afzelius to General Partner, strengthen Flagship's strategic direction and operational capabilities.

What critics are saying

  • The ambitious goal of creating 25 breakthrough companies may stretch resources and focus, potentially impacting the quality of each venture.
  • Heavy reliance on AI and advanced computational techniques could face technological and regulatory hurdles, slowing down progress.

What makes Flagship Pioneering unique

  • Flagship Pioneering's focus on creating and developing breakthrough companies in human health, sustainability, and AI sets it apart from traditional venture firms.
  • Their significant capital pool of $10.9 billion and $14 billion in assets under management provides unparalleled financial backing for innovative ventures.
  • Flagship's unique approach to leveraging generative AI for drug discovery and development accelerates the creation of transformative technologies.

Help us improve and share your feedback! Did you find this helpful?